Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carmoterol plus extrafine budesonide in adults with moderate persistent asthma
2006-000038-11Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carmoterol and budesonide in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoints: Efficacy, Safety and 1 more. Started Jun 2006; status: completed.
02
Drugs
carmoterolbudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000038-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000038-11.